Gate Science, founded with a mission to revolutionize pain management, focuses on developing wearable medical technology for effective and durable peripheral pain control without the use of narcotics. Their flagship product, RELAY, is designed to manage pain throughout the entire perioperative and postoperative period, addressing a critical gap in non-opioid therapies which typically only last up to five days. Gate Science aims to provide a single, comprehensive solution for patients recovering from major surgeries.
Notable figures associated with Gate Science include its executive team and a distinguished scientific advisory board. The company has garnered attention from investors interested in innovative healthcare solutions. Key achievements include the development and introduction of RELAY, which has the potential to significantly reduce reliance on narcotics for pain management. Gate Science's impact lies in its potential to transform postoperative care by offering a more effective and sustainable approach to pain control.
